{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:34:42Z","timestamp":1793345682494,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["302978"],"award-info":[{"award-number":["302978"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["303019"],"award-info":[{"award-number":["303019"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["MX\/a\/2019\/012325"],"award-info":[{"award-number":["MX\/a\/2019\/012325"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.molmed.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:11:19Z","timestamp":1748016679000},"page":"1032-1046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Acute lymphoblastic leukemia relapse: biomarkers, hopes, and challenges"],"prefix":"10.1016","volume":"31","author":[{"given":"Joseph","family":"Adomako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina E.","family":"Jim\u00e9nez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Victor M.","family":"Correa-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"N\u00fa\u00f1ez-Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0269-5884","authenticated-orcid":false,"given":"Michael","family":"Schnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2025.04.005_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/cancers10040110","article-title":"New challenges in targeting signaling pathways in acute lymphoblastic leukemia by NGS approaches: an update","volume":"10","author":"Monta\u00f1o","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2025.04.005_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.molmed.2025.04.005_bb0015","first-page":"659","article-title":"Identification of biomarkers for the prediction of relapse-free survival in pediatric B-precursor acute lymphoblastic leukemia","volume":"41","author":"Jing","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.molmed.2025.04.005_bb0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12098-023-04635-4","article-title":"Relapsed acute lymphoblastic leukemia","volume":"91","author":"Sidhu","year":"2024","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.molmed.2025.04.005_bb0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/OP.21.00843","article-title":"Updates in the management of relapsed and refractory acute lymphoblastic leukemia: an urgent plea for new treatments is being answered!","volume":"18","author":"Duvall","year":"2022","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.molmed.2025.04.005_bb0030","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3324\/haematol.2021.280395","article-title":"How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?","volume":"107","author":"Pinchinat","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2025.04.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29361","article-title":"Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse","volume":"69","author":"Anti\u0107","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.molmed.2025.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.04.005_bb0045","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2023020794","article-title":"Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0050","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/tp.2020.01.07","article-title":"Ras pathway mutation feature in the same individuals at diagnosis and relapse of childhood acute lymphoblastic leukemia","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.molmed.2025.04.005_bb0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.arcmed.2016.12.005","article-title":"Gene expression profiling of acute lymphoblastic leukemia in children with very early relapse","volume":"47","author":"N\u00fa\u00f1ez-Enr\u00edquez","year":"2016","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.molmed.2025.04.005_bb0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/2159-8290.CD-19-1059","article-title":"Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs","volume":"10","author":"Dobson","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molmed.2025.04.005_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.637975","article-title":"The origin of B-cells: human fetal B cell development and implications for the pathogenesis of childhood acute lymphoblastic leukemia","volume":"12","author":"Jackson","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3892\/ol.2020.11583","article-title":"Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: molecular pathways and disease treatments (Review)","volume":"20","author":"Huang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.molmed.2025.04.005_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.11.005","article-title":"The Ikaros family in lymphocyte development","volume":"51","author":"Heizmann","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.2023023153","article-title":"How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults","volume":"145","author":"Tran","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0090","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3324\/haematol.2018.207019","article-title":"BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy","volume":"105","author":"Cario","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2025.04.005_bb0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1186\/s12885-024-12828-z","article-title":"Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2025.04.005_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023606","article-title":"PAX5 alterations in B-cell acute lymphoblastic leukemia","volume":"12","author":"Jia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1101\/gad.240416.114","article-title":"Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia","volume":"28","author":"Liu","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2025.04.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033836","article-title":"PAX5 fusion genes in acute lymphoblastic leukemia: A literature review","volume":"102","author":"Fouad","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.molmed.2025.04.005_bb0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41375-024-02502-5","article-title":"PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome","volume":"39","author":"Caye-Eude","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0120","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1007\/s00277-024-05868-9","article-title":"Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements","volume":"103","author":"Cao","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0125","doi-asserted-by":"crossref","first-page":"15167","DOI":"10.1038\/s41598-023-42294-9","article-title":"Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment","volume":"13","author":"Burmeister","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2025.04.005_bb0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bjh.19370","article-title":"Relevance of CD20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia","volume":"204","author":"Bommannan","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/diagnostics12030724","article-title":"TP53 expression and mutational analysis in hematological malignancy in Jeddah, Saudi Arabia","volume":"12","author":"Alkhatabi","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.molmed.2025.04.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026286","article-title":"TP53 mutations in hypodiploid acute lymphoblastic leukemia","volume":"7","author":"Comeaux","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.molmed.2025.04.005_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/cancers14010032","article-title":"Near-haploidy and low-hypodiploidy in B-cell acute lymphoblastic leukemia: when less is too much","volume":"14","author":"Molina","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2025.04.005_bb0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjh.14474","article-title":"Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics","volume":"176","author":"Tasian","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2014-02-558833","article-title":"TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis","volume":"124","author":"Stengel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/biomedicines11030821","article-title":"Updates in KMT2A gene rearrangement in pediatric acute lymphoblastic leukemia","volume":"11","author":"G\u00f3recki","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.molmed.2025.04.005_bb0165","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2025.04.005_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1388154","article-title":"LINC00958 as new diagnostic and prognostic biomarker of childhood acute lymphoblastic leukaemia of B cells","volume":"14","author":"Altieri","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116903","article-title":"Identification of a circular RNA isoform of WASHC2A as a prognostic factor for high-risk paediatric B-ALL patients","volume":"177","author":"Filomena","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molmed.2025.04.005_bb0180","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajpath.2019.12.011","article-title":"Cortactin expression in hematopoietic cells","volume":"190","author":"Castellanos-Mart\u00ednez","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0185","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41375-018-0333-4","article-title":"High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse","volume":"33","author":"Vel\u00e1zquez-Avila","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0190","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41375-018-0353-0","article-title":"NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia","volume":"33","author":"Lopez-Millan","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0195","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41417-022-00491-0","article-title":"Functional characterization of the PI3K\/AKT\/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia","volume":"29","author":"Gr\u00fcninger","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.molmed.2025.04.005_bb0200","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","article-title":"Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia","volume":"6","author":"Ma","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2025.04.005_bb0205","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/leu.2017.303","article-title":"RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"32","author":"Jerchel","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nm.4505","article-title":"Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse","volume":"24","author":"Good","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2025.04.005_bb0215","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3390\/cancers14092089","article-title":"The bone marrow microenvironment in B-cell development and malignancy","volume":"14","author":"Hughes","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.molmed.2025.04.005_bb0220","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/stem.1794","article-title":"SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors","volume":"32","author":"Khurana","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2025.04.005_bb0225","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood.2021013506","article-title":"High BMP4 expression in low\/intermediate risk BCP-ALL identifies children with poor outcomes","volume":"139","author":"Fern\u00e1ndez-Sevilla","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5536","article-title":"Leukemia-on-a-chip: dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2025.04.005_bb0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3324\/haematol.2018.188664","article-title":"ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells","volume":"104","author":"Portale","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2025.04.005_bb0240","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/14728222.2020.1799350","article-title":"Activin A: an emerging target for improving cancer treatment?","volume":"24","author":"Ries","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.molmed.2025.04.005_bb0245","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3324\/haematol.2019.230334","article-title":"Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance","volume":"105","author":"Jonart","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2025.04.005_bb0250","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.3390\/ijms22094590","article-title":"State-of-art of cellular therapy for acute leukemia","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0255","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms23063067","article-title":"Resistance mechanisms in pediatric B-cell acute lymphoblastic leukemia","volume":"23","author":"J\u0119draszek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0260","first-page":"95","article-title":"Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia","volume":"11","author":"Ibrahim","year":"2018","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.molmed.2025.04.005_bb0265","doi-asserted-by":"crossref","first-page":"35615","DOI":"10.1038\/srep35615","article-title":"Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis","volume":"6","author":"Yamamoto","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2025.04.005_bb0270","doi-asserted-by":"crossref","first-page":"12074","DOI":"10.1038\/s41598-020-69059-y","article-title":"FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia","volume":"10","author":"Yu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2025.04.005_bb0275","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41375-024-02403-7","article-title":"Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia","volume":"38","author":"van der Ham","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11899-024-00735-w","article-title":"Glucocorticoid therapy in acute lymphoblastic leukemia: navigating short-term and long-term effects and optimal regimen selection","volume":"19","author":"Pourhassan","year":"2024","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.molmed.2025.04.005_bb0285","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-023-38456-y","article-title":"Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia","volume":"14","author":"Sarno","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2025.04.005_bb0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41420-024-02028-w","article-title":"PKA inhibition kills L-asparaginase-resistant leukemic cells from relapsed acute lymphoblastic leukemia patients","volume":"10","author":"Lee","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.molmed.2025.04.005_bb0295","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2025.04.005_bb0300","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1200\/JCO.23.02238","article-title":"Genomic determinants of outcome in acute lymphoblastic leukemia","volume":"42","author":"Chang","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0305","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1002\/cam4.4024","article-title":"The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia","volume":"10","author":"Mansur","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.molmed.2025.04.005_bb0310","first-page":"43","article-title":"How I treat ETP-ALL in children","volume":"45","author":"Summers","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BS9.0000000000000073","article-title":"MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies","volume":"3","author":"Li","year":"2021","journal-title":"Blood Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0320","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood-2013-08-522698","article-title":"c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells","volume":"123","author":"Roderick","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0325","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.2019000982","article-title":"IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia","volume":"134","author":"Gonz\u00e1lez-Garc\u00eda","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0330","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood.2023020490","article-title":"Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia","volume":"143","author":"Zhang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0335","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2457777","article-title":"Targeting the IKZF1\/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemia","volume":"26","author":"Li","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.molmed.2025.04.005_bb0340","article-title":"Efficient T cell migration and activation require L-plastin","volume":"29","author":"Joshi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0345","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jleuko\/qiad001","article-title":"T cell functions and organ infiltration by leukemic T cells require cortactin","volume":"113","author":"Castellanos-Mart\u00ednez","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/2643-3230.BCD-20-0093","article-title":"T-cell acute lymphoblastic leukemia: a roadmap to targeted therapies","volume":"2","author":"Cordo","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.molmed.2025.04.005_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.3","article-title":"Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia","volume":"7","author":"Richter-Pecha\u0144ska","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.molmed.2025.04.005_bb0360","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3324\/haematol.2016.146381","article-title":"The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia","volume":"101","author":"Mendes","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2025.04.005_bb0365","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1038\/onc.2015.462","article-title":"Oncogenic PTEN functions and models in T-cell malignancies","volume":"35","author":"Tesio","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2025.04.005_bb0370","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood.2023022455","article-title":"Targeting the TNF\/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia","volume":"143","author":"\u00c1vila \u00c1vila","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2025.04.005_bb0375","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1200\/JCO.23.01351","article-title":"Future of treatment of adolescents and young adults with ALL: a vision for collaboration and equity","volume":"42","author":"Newman","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0380","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cas.15583","article-title":"Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia","volume":"114","author":"Yasuda","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0385","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/10428194.2024.2416569","article-title":"Novel prognostic factors and therapeutic advances in adult acute lymphoblastic leukemia","volume":"66","author":"Ribera","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.molmed.2025.04.005_bb0390","series-title":"The EBMT Handbook","first-page":"659","article-title":"Acute lymphoblastic leukaemia in children and adolescents","author":"Peters","year":"2024"},{"key":"10.1016\/j.molmed.2025.04.005_bb0395","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-021-01043-9","article-title":"Childhood acute leukemias in developing nations: successes and challenges","volume":"23","author":"Zapata-Tarr\u00e9s","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.molmed.2025.04.005_bb0400","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/diagnostics13172748","article-title":"Proteomics in childhood acute lymphoblastic leukemia: challenges and opportunities","volume":"13","author":"Kourti","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.molmed.2025.04.005_bb0405","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/cancers16040723","article-title":"Treatment of pediatric acute lymphoblastic leukemia: a historical perspective","volume":"16","author":"Hayashi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.molmed.2025.04.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111356","article-title":"Global, regional, and national burden of acute lymphoblastic leukemia in children: Epidemiological trends analysis from 1990 to 2021","volume":"27","author":"Hu","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.molmed.2025.04.005_bb0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/GO-24-12500","article-title":"Racial disparities in pediatric patients with acute lymphoblastic leukemia: an NCDB analysis","volume":"10","author":"Mishra","year":"2024","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1509943","article-title":"Editorial: childhood leukemias in Latin America: epidemiology, causality, novel predictive profiles and therapeutic strategies","volume":"14","author":"N\u00fa\u00f1ez-Enr\u00edquez","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1304690","article-title":"Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy","volume":"14","author":"N\u00fa\u00f1ez-Enr\u00edquez","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0430","first-page":"6885","article-title":"Application of MRD monitoring in pediatric patients with ALL","volume":"22","author":"Qin","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0435","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.exphem.2015.05.015","article-title":"Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia","volume":"43","author":"Ghazavi","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0440","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.3390\/ijms22094426","article-title":"The bone marrow niche in B-cell acute lymphoblastic leukemia: the role of microenvironment from pre-leukemia to overt leukemia","volume":"22","author":"Dander","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0445","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41375-018-0144-7","article-title":"New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment","volume":"32","author":"Cheung","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2025.04.005_bb0450","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phoj.2021.03.003","article-title":"CNS relapse of childhood ALL: more than meets the eye: CNS relapse in ALL","volume":"6","author":"Roy","year":"2021","journal-title":"Pediatr. Hematol. Oncol. J."},{"key":"10.1016\/j.molmed.2025.04.005_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.606540","article-title":"Toward therapeutic targeting of bone marrow leukemic niche protective signals in B-cell acute lymphoblastic leukemia","volume":"10","author":"Delahaye","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0460","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fendo.2020.00294","article-title":"Obesity-induced changes in bone marrow homeostasis","volume":"11","author":"Benova","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0465","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0041-1730752","article-title":"Isolated CNS relapse in acute lymphoblastic leukemia (ALL): an experience from a tertiary care center","volume":"13","author":"Tevatia","year":"2021","journal-title":"J. Lab. Physicians"},{"key":"10.1016\/j.molmed.2025.04.005_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114015","article-title":"The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia","volume":"437","author":"Enlund","year":"2024","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2025.04.005_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10516","article-title":"From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment","volume":"5","author":"Soto","year":"2021","journal-title":"JBMR Plus"},{"key":"10.1016\/j.molmed.2025.04.005_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746492","article-title":"Patient-derived bone marrow spheroids reveal leukemia-initiating cells supported by mesenchymal hypoxic niches in pediatric B-ALL","volume":"12","author":"Balandr\u00e1n","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0485","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/ijms23052755","article-title":"Genetic biomarkers and their clinical implications in B-cell acute lymphoblastic leukemia in children","volume":"23","author":"Lejman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.04.005_bb0490","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/gcc.22163","article-title":"Acute lymphoblastic leukemia with low hypodiploid\/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%","volume":"53","author":"M\u00fchlbacher","year":"2014","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.molmed.2025.04.005_bb0495","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjh.17879","article-title":"B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification","volume":"197","author":"Yeung","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0500","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2025.04.005_bb0505","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3389\/fonc.2019.01496","article-title":"Drug resistance biomarkers and their clinical applications in childhood acute lymphoblastic leukemia","volume":"9","author":"Aberuyi","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2025.04.005_bb0510","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11684-020-0821-6","article-title":"Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia","volume":"15","author":"Li","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.molmed.2025.04.005_bb0515","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41375-019-0430-z","article-title":"PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia","volume":"33","author":"Bastian","year":"2019","journal-title":"Leukemia"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491425001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491425001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:52:53Z","timestamp":1778615573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491425001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1471491425001078"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2025.04.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute lymphoblastic leukemia relapse: biomarkers, hopes, and challenges","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}